The detection rate of KRAS‐positive lung cancers analyzed by blood and tissue samples differs, and the detection rate of blood samples may be poor, especially in the case of mucinous adenocarcinoma with lung metastases only. This evidence concerns the gene KRAS and colon mucinous adenocarcinoma.